Akebia Therapeutics
AKBA
AKBA
151 hedge funds and large institutions have $421M invested in Akebia Therapeutics in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 29 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 37
39% less capital invested
Capital invested by funds: $694M → $421M (-$273M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
151
Holding in Top 10
–
Calls
$24.4M
Puts
$695K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$8.45M | |
| 3 | +$7.89M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.86M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.11M |
Top Sellers
| 1 | -$14M | |
| 2 | -$11.7M | |
| 3 | -$9.35M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$4.95M |
| 5 |
SIM
Spark Investment Management
New York
|
-$4M |